Anti-inflammatory treatment of asthma: Differentiation and trial-and-error

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 8, 2009, Pages 1237-1241

  Wolthers, Ole D ^a  

^a Children's Clinic Randers   (Denmark)

Author keywords

Asthma; Asthma drugs; Inhaled steroids; Paediatrics; Wheeze

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST;

ADRENAL SUPPRESSION; ASTHMA; ATOPY; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; GROWTH INHIBITION; HEREDITY; HUMAN; LOW DRUG DOSE; MEDICAL DECISION MAKING; PATIENT COMPLIANCE; POPULATION; PRIORITY JOURNAL; SHORT SURVEY; SIDE EFFECT; VIRUS INFECTION; WHEEZING;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; HUMANS; LEUKOTRIENE ANTAGONISTS; MEDICATION ADHERENCE; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY SOUNDS; SEVERITY OF ILLNESS INDEX;

EID: 68249128376     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01351.x     Document Type: Short Survey

References (27)

1. Brand PLP, Baraldi E, Bisgaard H, Boner AL, Castro-Rodriquez JA, Custovic A, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence base approach. Eur Respir J 2008 32 : 1096 110.
2. Bacharier LB, Boner A, Carlsen KH, Eigenmann PA, Frischer T, Götz M, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008 63 : 5 34. (Pubitemid 350198248)
3. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. Am J Respir Crit Care Med 1998 157 : S1 S53.
4. Carlsen KH. Pharmaceutical treatment of asthma in children. Curr Drug Targets Inflamm Allergy 2005 4 : 543 9.
5. Murray C. Can inhaled corticosteroids influence the natural history of asthma? Curr Opin Allergy Clin Immunol 2008 8 : 77 81.
6. Busse WW, Pedersen S, Puwels RA, Tan WC, Chen YZ, Lam CJ, et al. The steroid treatment as regular therapy in early asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 2008 121 : 1167 74.
7. Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Martinez FD. Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol 2003 111 : 661 75.
8. Wasserman RL, Baker JW, Kim JW, Blake KV, Scott CA, Wu W, et al. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study. Ann Allergy Asthma Immunol 2006 96 : 808 18.
9. Heymann PW, Platts-Mills TA, Johnston SL. Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults. Pediatr Infect Dis J 2005 24 : S217 22.
10. Daley-Yates PT. Pharmacological aspects of glucocorticoid therapy. In : Wolthers OD, editor. Exogenous glucocorticoids in paediatric asthma. Kerala : Transworld Research Network, 2007.
11. Wolthers OD. Impact of inhaled and intranasal corticosteroids on the growth of children. BioDrugs 2000 13 : 347 57.
12. Todd GR, Acerini CL, Buck JJ, Murphy NP, Ross-Russell R, Warner JT, et al. Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate. Eur Respir J 2002 19 : 1207 9.
13. Wolthers OD. Methodology and implications of knemometry in growth assessment of inhaled glucocorticoids. J Pediatr Allergy Immunol 2009 (Epub of print). DOI: 10.1111/j.1399-3038.2009.00882.x
14. Bisgaard H. Effect of long-acting beta2 agonists on exacerbation rates of asthma in children. Pediatr Pulmonol 2003 36 : 391 8.
15. Bisgaard H, Le Roux P, Bjåmer D, Dymek A, Vermeulen JH, Hultquist C. Budesonide/Formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest 2006 130 : 1733 43.
16. Ducharme F, Schwartz Z, Kakuma R. Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003133. DOI: 10.1002/14651858.CD003133. pub2
17. Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001 108 : E48, 1 10.
18. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000 16 : 802 7.
19. Spector S. Noncompliance with asthma therapy-are there solutions? J Asthma 2000 37 : 381 8.
20. Watts RW, McLennan G, Bassham I, el-Saadi O. Do patients with asthma fill their prescriptions? A primary compliance study. Aust Fam Physician 1997 26 : S4 S6.
21. Amirav I, Newhouse MT. Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics 2001 108 : 389 94.
22. Esposito-Festen J, Ates B, van Vliet F, Hop W, Tiddens H. Aerosol therapy to young children by pMDI-spacer: is facemask design important? Pediatr Allergy Immunol 2005 16 : 348 53.
23. Jonasson G, Carlsen KH, Mowinckel P. Asthma drug adherence in a long term clinical trial. Arch Dis Child 2000 83 : 330 3.
24. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996 98 : 1057 61.
25. Maspero JF, Duenas-Meza E, Volovitz B, Pinacho Caza C, Kosa L, Vrijens F, et al. Oral montelukast versus beclomethasone in 6-11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy. Cur Med Res Opinion 2001 17 : 96 04.
26. Szefler SJ, Baker JW, Uryniak T, Goldman M, Silkoff PE. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma. J Allergy Clin Immunol 2007 120 : 1043 50.
27. Bjermer L. Montelukast in the treatment of asthma as a systemic disease. Expert Rev Clin Immunol 2005 1 : 325 36.